Jen Larson | Senior Vice President-Finance and Investor Relations |
Steve Hoerter | President and Chief Executive Officer |
Dan Martin | Chief Commercial Officer |
Matt Sherman | Chief Medical Officer |
Margarida Duarte | Head-International |
Tucker Kelly | Chief Financial Officer |
Daniel Wolle | JPMorgan |
Paul Jeng | Guggenheim |
Tyler Van Buren | Cowen |
Eun Yang | Jefferies |
Nicole Gabreski | Piper Sandler |
Brad Canino | Stifel |
Peter Lawson | Barclays |
Good morning, everyone, and welcome to Deciphera Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Jen Larson, Senior Vice President of Finance and Investor Relations.